Australian Pharmacist

The popular weight-loss drug Wegovy has been approved to treat cardiovascular disease in patients who are overweight or obese.

Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.

In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.

How pharmacists can support patients in the end-of-life period.

This week pharmacists will see a suite of regulatory and funding changes take effect. Here are the six key updates pharmacists need to know before...

The journey through the Australian healthcare system has been long and hard for this pharmacist patient with Hypermobile Ehlers-Danlos syndrome.